Pharmacological therapy for acute spinal cord injury

Neurosurgery

Volumn 72, Issue SUPPL.2, 2013, Pages 93-105

  Hurlbert, R John ^a   Hadley, Mark N ^b   Walters, Beverly C ^b,d   Aarabi, Bizhan ^e   Dhall, Sanjay S ^g   Gelb, Daniel E ^f   Rozzelle, Curtis J ^c   Ryken, Timothy C ^h   Theodore, Nicholas ⁱ  

^a UNIVERSITY OF CALGARY   (Canada)

^b Division of Orthopaedic Surgery   (United States)

^c University of Alabama at Birmingham   (United States)

^d BETTY AND GUY BEATTY CENTER FOR INTEGRATED RESEARCH   (United States)

^e Department of Neurosurgery ^*  (United States)

^f UNIVERSITY OF MARYLAND   (United States)

^g EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

^h UNIVERSITY OF IOWA   (United States)

ⁱ BARROW NEUROLOGICAL INSTITUTE   (United States)

Author keywords

GM 1 ganglioside; Mehtylprednisolone; NASCIS trials; Pharmacologic therapy; Sygen trials

Indexed keywords

GANGLIOSIDE GM1; GANGLIOSIDE GM1 ANTIBODY; METHYLPREDNISOLONE; PLACEBO; NALOXONE; NIMODIPINE; STEROID; TIRILAZAD;

ARTICLE; ATELECTASIS; BRAIN HEMATOMA; CELL DENSITY; COHORT ANALYSIS; COMORBIDITY; DEATH; DRUG MEGADOSE; ELECTROMYOGRAPHY; GASTROINTESTINAL HEMORRHAGE; HUMAN; INJURY SEVERITY; INTENSIVE CARE UNIT; LOADING DRUG DOSE; MONOCYTE; NEUROPROTECTION; NUCLEAR MAGNETIC RESONANCE IMAGING; PEPTIC ULCER; PNEUMONIA; PRIORITY JOURNAL; RESPIRATORY FAILURE; SPINAL CORD INJURY; TUMOR LYSIS SYNDROME; ULCER PERFORATION; URINARY TRACT INFECTION; ACUTE DISEASE; DRUG EFFICACY; DRUG THERAPY; RANDOMIZED CONTROLLED TRIAL (TOPIC); SPINAL CORD SURGERY;

CERVICAL VERTEBRAE; HUMANS; NEUROPROTECTIVE AGENTS; PRACTICE GUIDELINES AS TOPIC; SPINAL CORD INJURIES;

EID: 84923472198     PISSN: 0148396X     EISSN: None     Source Type: Journal    
DOI: 10.1227/NEU.0b013e31827765c6     Document Type: Article

References (33)

1. Kwon BK, Okon E, Hillyer J, et al. A systematic review of non-invasive pharmacologic neuroprotective treatments for acute spinal cord injury. J Neurotrauma. 2011;28(8):1545-1588.
2. Bracken MB, Shepard MJ, Collins WF, et al. A randomized, controlled trial of methylprednisolone or naloxone in the treatment of acute spinal-cord injury. Results of the Second National Acute Spinal Cord Injury Study. N Engl J Med. 1990;322(20):1405-1411.
3. Pitts LH, Ross A, Chase GA, Faden AI. Treatment with thyrotropin- releasing hormone (TRH) in patients with traumatic spinal cord injuries. J Neurotrauma. 1995;12(3):235-243.
4. Bracken MB, Shepard MJ, Holford TR, et al. Administration of methylprednisolone for 24 or 48 hours or tirilazad mesylate for 48 hours in the treatment of acute spinal cord injury. Results of the Third National Acute Spinal Cord Injury Randomized Controlled Trial. National Acute Spinal Cord Injury Study. JAMA. 1997;277(20):1597-1604.
5. Pharmacological therapy after acute cervical spinal cord injury. In: Guidelines for the management of acute cervical spine and spinal cord injuries. Neurosurgery. 2002;50(3 suppl):S63-S72.
6. Bracken MB, Shepard MJ, Holford TR, et al. Methylprednisolone or tirilazad mesylate administration after acute spinal cord injury: 1-year follow up. Results of the third National Acute Spinal Cord Injury randomized controlled trial. J Neurosurg. 1998;89(5):699-706.
7. Bracken MB, Shepard MJ, Collins WF Jr, et al. Methylprednisolone or naloxone treatment after acute spinal cord injury: 1-year follow-up data. Results of the second National Acute Spinal Cord Injury Study. J Neurosurg. 1992;76(1):23-31.
8. Bracken MB, Collins WF, Freeman DF, et al. Efficacy of methylprednisolone in acute spinal cord injury. JAMA. 1984;251(1):45-52.
9. Bracken MB, Shepard MJ, Hellenbrand KG, et al. Methylprednisolone and neurological function 1 year after spinal cord injury. Results of the National Acute Spinal Cord Injury Study. J Neurosurg. 1985;63(5):704-713.
10. Bracken MB. The use of methylprednisolone. J Neurosurg. 2000;93(2 suppl):340-341.
11. Bracken MB, Holford TR. Effects of timing of methylprednisolone or naloxone administration on recovery of segmental and long-tract neurological function in NASCIS 2. J Neurosurg. 1993;79(4):500-507.
12. Galandiuk S, Raque G, Appel S, Polk HC Jr. The two-edged sword of large-dose steroids for spinal cord trauma. Ann Surg. 1993;218(4):419-427.
13. Kiwerski JE. Application of dexamethasone in the treatment of acute spinal cord injury. Injury. 1993;24:457-460.
14. Otani K, Abe H, Kadoya S, et al. Beneficial effect of methylprednisolone sodium succinate in the treatment of acute spinal cord injury [translated version]. Sekitsu Sekizui. 1994;7:633-647.
15. Prendergast MR, Saxe JM, Ledgerwood AM, Lucas CE, Lucas WF. Massive steroids do not reduce the zone of injury after penetrating spinal cord injury. J Trauma. 1994;37(4):576-579.
16. Gerhart KA, Johnson RL, Menconi J, Hoffman RE, Lammertse DP. Utilization and effectiveness of methylprednisolone in a population-based sample of spinal cord injured persons. Paraplegia. 1995;33(6):316-321.
17. George ER, Scholten DJ, Buechler CM, Jordan-Tibbs J, Mattice C, Albrecht RM. Failure of methylprednisolone to improve the outcome of spinal cord injuries. Am Surg. 1995;61(8):659-664.
18. Gerndt SJ, Rodriguez JL, Pawlik JW, et al. Consequences of high-dose steroid therapy for acute spinal cord injury. J Trauma. 1997;42(2):279-284.
19. Poynton AR, O'Farrell DA, Shannon F, Murray P, McManus F, Walsh MG. An evaluation of the factors affecting neurological recovery following spinal cord injury. Injury. 1997;28(8):545-548.
20. Pointillart V, Petitjean ME, Wiart L, et al. Pharmacological therapy of spinal cord injury during the acute phase. Spinal Cord. 2000;38(2):71-76.
21. Matsumoto T, Tamaki T, Kawakami M, Yoshida M, Ando M, Yamada H. Early complications of high-dose methylprednisolone sodium succinate treatment in the follow-up of acute cervical spinal cord injury. Spine (Phila Pa 1976). 2001;26(4): 426-430.
22. Pollard ME, Apple DF. Factors associated with improved neurologic outcomes in patients with incomplete tetraplegia. Spine (Phila Pa 1976). 2003;28(1): 33-38.
23. Aito S, D'Andrea M, Werhagen L. Spinal cord injuries due to diving accidents. Spinal Cord. 2005;43(2):109-116.
24. Qian T, Guo X, Levi AD, Vanni S, Shebert RT, Sipski ML. High-dose methylprednisolone may cause myopathy in acute spinal cord injury patients. Spinal Cord. 2005;43(4):199-203.
25. Tsutsumi S, Ueta T, Shiba K, Yamamoto S, Takagishi K. Effects of the Second National Acute Spinal Cord Injury Study of high-dose methylprednisolone therapy on acute cervical spinal cord injury-results in spinal injuries center. Spine (Phila Pa 1976). 2006;31(26):2992-2996.
26. Lee HC, Cho DY, Lee WY, Chuang HC. Pitfalls in treatment of acute cervical spinal cord injury using high-dose methylprednisolone: a retrospect audit of 111 patients. Surg Neurol. 2007;68(suppl 1):37-42.
27. Leypold BG, Flanders AE, Schwartz ED, Burns AS. The impact of methylprednisolone on lesion severity following spinal cord injury. Spine (Phila Pa 1976). 2007;32(3):373-378.
28. Suberviola B, González-Castro A, Llorca J, Ortiz-Melón F, Miñambres E. Early complications of high-dose methylprednisolone in acute spinal cord injury patients. Injury. 2008;39(7):748-752.
29. Ito Y, Sugimoto Y, Tomioka M, Kai N, Tanaka M. Does high dose methylprednisolone sodium succinate really improve neurological status in patient with acute cervical cord injury?: a prospective study about neurological recovery and early complications. Spine (Phila Pa 1976). 2009;34(20): 2121-2124.
30. Tsao YT, Chen WL, Tsai WC. Steroids for acute spinal cord injury: revealing silent pathology. Lancet. 2009;374(9688):500.
31. Edwards P, Arango M, Balica L; CRASH trial collaborators. Final results of MRC CRASH, a randomised placebo-controlled trial of intravenous corticosteroid in adults with head injury-outcomes at 6 months. Lancet. 2005;365(9475): 1957-1959.
32. Geisler FH, Dorsey FC, Coleman WP. Recovery of motor function after spinalcord injury-a randomized, placebo-controlled trial with GM-1 ganglioside. N Engl J Med. 1991;324(26):1829-1838.
33. Geisler FH, Coleman WP, Grieco G, Poonian D; Sygen Study Group. The Sygen multicenter acute spinal cord injury study. Spine (Phila Pa 1976). 2001;26(245): S87-S98.